Diabetes, Vol 34, Issue 9 876-883, Copyright © 1985 by American Diabetes Association

ARTICLES

A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy

CV Jackson, GM McGrath, AG Tahiliani, RV Vadlamudi and JH McNeill

The effects of experimental diabetes on cardiac function and ultrastructure were studied in rats that had been diabetic for 6-24 wk. Experimental diabetes was produced by the intravenous (i.v.) injection of 65 mg/kg streptozocin (STZ) into rats 42-43 days old. Diabetic rat hearts perfused at 15 cm H2O on the working heart apparatus demonstrated depressed cardiac function (i.e., lower left ventricular pressure and +/- dP/dt) at 6, 12, and 24 wk of diabetes. Electron microscopic analysis of ventricular myocardium revealed increased lipid deposition from 6 to 24 wk of diabetes and progressive deterioration of the myocardial cell integrity at 12 and 24 wk of diabetes. This deterioration was characterized by loss of contractile protein, vacuolization (swollen sarcoplasmic reticulum), myelin formations, myocytolysis, and contracture bands. These alterations paralleled the depression of cardiac function at 12 and 24 wk of diabetes. There was, however, depressed function at 6 wk of diabetes but no observable alterations in myocardial ultrastructure. Therefore, experimental diabetes produced ultrastructural alterations in the rat heart that manifested themselves only after a demonstrable depression in cardiac function.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C. N. Mowa, S. Maeda, Y. Hattori, and T. Miyauchi Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1030 - E1040. [Abstract] [Full Text] [PDF]

				I. G. Poornima, P. Parikh, and R. P. Shannon Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis Circ. Res., March 17, 2006; 98(5): 596 - 605. [Abstract] [Full Text] [PDF]

				S. Ghosh, D. Qi, D. An, T. Pulinilkunnil, A. Abrahani, K.-H. Kuo, R. B. Wambolt, M. Allard, S. M. Innis, and B. Rodrigues Brief episode of STZ-induced hyperglycemia produces cardiac abnormalities in rats fed a diet rich in n-6 PUFA Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2518 - H2527. [Abstract] [Full Text] [PDF]

				H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart Arch Intern Med, September 13, 2004; 164(16): 1737 - 1748. [Abstract] [Full Text] [PDF]

				G. J.S. Cooper, A. R.J. Phillips, S. Y. Choong, B. L. Leonard, D. J. Crossman, D. H. Brunton, E. L. Saafi, A. M. Dissanayake, B. R. Cowan, A. A. Young, et al. Regeneration of the Heart in Diabetes by Selective Copper Chelation Diabetes, September 1, 2004; 53(9): 2501 - 2508. [Abstract] [Full Text] [PDF]

				P. Pacher, L. Liaudet, F. G. Soriano, J. G. Mabley, E. Szabo, and C. Szabo The Role of Poly(ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothelial Dysfunction in Diabetes Diabetes, February 1, 2002; 51(2): 514 - 521. [Abstract] [Full Text] [PDF]

				A. Babsky, N. Doliba, N. Doliba, A. Savchenko, S. Wehrli, and M. Osbakken Na+ Effects on Mitochondrial Respiration and Oxidative Phosphorylation in Diabetic Hearts Experimental Biology and Medicine, June 1, 2001; 226(6): 543 - 551. [Abstract] [Full Text] [PDF]

				D. D. Belke, T. S. Larsen, E. M. Gibbs, and D. L. Severson Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1104 - E1113. [Abstract] [Full Text] [PDF]

				J. Wada and Y. S. Kanwar Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney PNAS, January 6, 1998; 95(1): 144 - 149. [Abstract] [Full Text] [PDF]

				A. Tosaki and D. K. Das Extracellular Mg++ Manipulation Prevents the Proarrhythmic Activity of Cromakalim in Ischemic/Reperfused Diabetic Hearts J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 309 - 317. [Abstract] [Full Text]

				A. I. M. Al-Shafei, R. G. Wise, G. A. Gresham, G. Bronns, T. A. Carpenter, L. D. Hall, and C. L.-H. Huang Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats J. Physiol., January 9, 2002; 538(2): 541 - 553. [Abstract] [Full Text] [PDF]

				A. I. M. Al-Shafei, R. G. Wise, G. A. Gresham, T. A. Carpenter, L. D. Hall, and C. L.-H. Huang Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition J. Physiol., January 9, 2002; 538(2): 555 - 572. [Abstract] [Full Text] [PDF]